333 related articles for article (PubMed ID: 33803806)
1. The Role of Myeloid-Derived Suppressor Cells (MDSCs) in the Development and/or Progression of Endometriosis-State of the Art.
Suszczyk D; Skiba W; Jakubowicz-Gil J; Kotarski J; Wertel I
Cells; 2021 Mar; 10(3):. PubMed ID: 33803806
[TBL] [Abstract][Full Text] [Related]
2. Alteration of Myeloid-Derived Suppressor Cells, Chronic Inflammatory Cytokines, and Exosomal miRNA Contribute to the Peritoneal Immune Disorder of Patients With Endometriosis.
Chen Y; Wang K; Xu Y; Guo P; Hong B; Cao Y; Wei Z; Xue R; Wang C; Jiang H
Reprod Sci; 2019 Aug; 26(8):1130-1138. PubMed ID: 30453861
[TBL] [Abstract][Full Text] [Related]
3. MDSCs drive the process of endometriosis by enhancing angiogenesis and are a new potential therapeutic target.
Zhang T; Zhou J; Man GCW; Leung KT; Liang B; Xiao B; Ma X; Huang S; Huang H; Hegde VL; Zhong Y; Li Y; Kong GWS; Yiu AKW; Kwong J; Ng PC; Lessey BA; Nagarkatti PS; Nagarkatti M; Wang CC
Eur J Immunol; 2018 Jun; 48(6):1059-1073. PubMed ID: 29460338
[TBL] [Abstract][Full Text] [Related]
4. Myeloid-derived suppressor cells: A new emerging player in endometriosis.
Zhang T; He Y; Man GCW; Ding Y; Wang CC; Chung JPW
Int Rev Cell Mol Biol; 2023; 375():191-220. PubMed ID: 36967153
[TBL] [Abstract][Full Text] [Related]
5. CD33
Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
[TBL] [Abstract][Full Text] [Related]
6. Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis.
He Y; Hung SW; Liang B; Zhang R; Gao Y; Chu CY; Zhang T; Xu H; Chung JPW; Wang CC
Front Immunol; 2021; 12():641206. PubMed ID: 34367125
[TBL] [Abstract][Full Text] [Related]
7. Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma.
Binsfeld M; Muller J; Lamour V; De Veirman K; De Raeve H; Bellahcène A; Van Valckenborgh E; Baron F; Beguin Y; Caers J; Heusschen R
Oncotarget; 2016 Jun; 7(25):37931-37943. PubMed ID: 27177328
[TBL] [Abstract][Full Text] [Related]
8. Myeloid-Derived Suppressor Cells in Sepsis.
Schrijver IT; Théroude C; Roger T
Front Immunol; 2019; 10():327. PubMed ID: 30873175
[TBL] [Abstract][Full Text] [Related]
9. On the origin of myeloid-derived suppressor cells.
Millrud CR; Bergenfelz C; Leandersson K
Oncotarget; 2017 Jan; 8(2):3649-3665. PubMed ID: 27690299
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-derived suppressor cells: The green light for myeloma immune escape.
Malek E; de Lima M; Letterio JJ; Kim BG; Finke JH; Driscoll JJ; Giralt SA
Blood Rev; 2016 Sep; 30(5):341-8. PubMed ID: 27132116
[TBL] [Abstract][Full Text] [Related]
11. Myeloid-derived suppressor cells in obstetrical and gynecological diseases.
Zheng ZM; Yang HL; Lai ZZ; Wang CJ; Yang SL; Li MQ; Shao J
Am J Reprod Immunol; 2020 Aug; 84(2):e13266. PubMed ID: 32418253
[TBL] [Abstract][Full Text] [Related]
12. Beyond immunosuppressive effects: dual roles of myeloid-derived suppressor cells in bone-related diseases.
Ling Z; Yang C; Tan J; Dou C; Chen Y
Cell Mol Life Sci; 2021 Dec; 78(23):7161-7183. PubMed ID: 34635950
[TBL] [Abstract][Full Text] [Related]
13. Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression.
Bruno A; Mortara L; Baci D; Noonan DM; Albini A
Front Immunol; 2019; 10():771. PubMed ID: 31057536
[TBL] [Abstract][Full Text] [Related]
14. Novel role of microphthalmia-associated transcription factor in modulating the differentiation and immunosuppressive functions of myeloid-derived suppressor cells.
Lee A; Park H; Lim S; Lim J; Koh J; Jeon YK; Yang Y; Lee MS; Lim JS
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36627143
[TBL] [Abstract][Full Text] [Related]
15. Expansion of monocytic myeloid-derived suppressor cells in endometriosis patients: A pilot study.
Chen H; Qin S; Lei A; Li X; Gao Q; Dong J; Xiao Q; Zhou J
Int Immunopharmacol; 2017 Jun; 47():150-158. PubMed ID: 28407569
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-Derived Suppressor Cells (MDSCs) in Ovarian Cancer-Looking Back and Forward.
Okła K
Cells; 2023 Jul; 12(14):. PubMed ID: 37508575
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression.
Groth C; Hu X; Weber R; Fleming V; Altevogt P; Utikal J; Umansky V
Br J Cancer; 2019 Jan; 120(1):16-25. PubMed ID: 30413826
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu.
Wang XQ; Zhou WJ; Luo XZ; Tao Y; Li DJ
Hum Reprod; 2017 Jun; 32(6):1304-1317. PubMed ID: 28383711
[TBL] [Abstract][Full Text] [Related]
19. A Call for Epidemiological Research on Myeloid-Derived Suppressor Cells in Ovarian Cancer: A Review of the Existing Immunological Evidence and Suggestions for Moving Forward.
Stenzel AE; Abrams SI; Moysich KB
Front Immunol; 2019; 10():1608. PubMed ID: 31354741
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil might impair maternal-fetal immunotolerance by suppressing myeloid-derived suppressor cells in mice.
Jiang HH; Wang KX; Bi KH; Lu ZM; Zhang JQ; Cheng HR; Zhang MY; Su JJ; Cao YX
J Reprod Immunol; 2020 Nov; 142():103175. PubMed ID: 32682164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
